JPS5762219A - Ophthalmic solution - Google Patents

Ophthalmic solution

Info

Publication number
JPS5762219A
JPS5762219A JP13743280A JP13743280A JPS5762219A JP S5762219 A JPS5762219 A JP S5762219A JP 13743280 A JP13743280 A JP 13743280A JP 13743280 A JP13743280 A JP 13743280A JP S5762219 A JPS5762219 A JP S5762219A
Authority
JP
Japan
Prior art keywords
ophthalmic solution
solution
active agent
surface active
cationic surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13743280A
Other languages
Japanese (ja)
Inventor
Nobuo Kojima
Takao Yokoo
Seiichi Kanochi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP13743280A priority Critical patent/JPS5762219A/en
Publication of JPS5762219A publication Critical patent/JPS5762219A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: A transparent ophthalmic solution preventing the cloud of the solution and the reduction in antimicrobial action, obtained by blending a glycyrrhetinate with a cationic surface active agent and by adjusting a pH to a specific range.
CONSTITUTION: A glycyrrhetinate (e.g., disodium salt, dipotassium salt, etc.) and a cationic surface active agent are dissolved in water and a pH of a solution is adjusted to 5.9W7.0 to give a transparent ophthalmic solution. Beanzalkonium chloride, benzethonium chloride, etc. may be cited as the cationic surface active agent. In preparing pH, a buffering system, e.g., buffering system of borateborax, system of alkali metal-phosphate, etc. may be used. The prepared ophthalmic solution is not clouded and it is transparent, exhibiting strong antibacterial action on Pseudomonas aeruginosa, etc.
COPYRIGHT: (C)1982,JPO&Japio
JP13743280A 1980-10-01 1980-10-01 Ophthalmic solution Pending JPS5762219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13743280A JPS5762219A (en) 1980-10-01 1980-10-01 Ophthalmic solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13743280A JPS5762219A (en) 1980-10-01 1980-10-01 Ophthalmic solution

Publications (1)

Publication Number Publication Date
JPS5762219A true JPS5762219A (en) 1982-04-15

Family

ID=15198480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13743280A Pending JPS5762219A (en) 1980-10-01 1980-10-01 Ophthalmic solution

Country Status (1)

Country Link
JP (1) JPS5762219A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149671A (en) * 1985-12-24 1987-07-03 Lion Corp Liquid agent containing tocopherol compound
JP2019006710A (en) * 2017-06-26 2019-01-17 小林製薬株式会社 Aqueous preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149671A (en) * 1985-12-24 1987-07-03 Lion Corp Liquid agent containing tocopherol compound
JPH0647536B2 (en) * 1985-12-24 1994-06-22 ライオン株式会社 Liquid containing tocopherols
JP2019006710A (en) * 2017-06-26 2019-01-17 小林製薬株式会社 Aqueous preparation

Similar Documents

Publication Publication Date Title
EP0013077A3 (en) Glass composition and its use in a therapeutic composition, in a subcutaneous implant or in a fertilizer, algicide, fungicide, or molluscicide
GB1527605A (en) Insulin preparation for intranasal administration
CA2003198A1 (en) Aqueous ophthalmic solutions and method for preserving same
BG100915A (en) Ophthalmic composition with decreased viscosity
MY122333A (en) Herbicidal compositions and surfactant concentrates
GR3020717T3 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
ES510245A0 (en) "A METHOD TO OBTAIN AN INSULIN PREPARATION".
AU2388392A (en) Oxicam or oxicam derivatives-containing ophthalmic compositions
JPS5762219A (en) Ophthalmic solution
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
JPS6416728A (en) Aqueous preparation
AU550658B2 (en) Dialkyl sulphosuccinates detergents with added magnesium ions
JPS5762218A (en) Ophthalmic solution
JPS6487601A (en) Production of fucoidan
JPS55127109A (en) Coagulant
YU226189A (en) Water solutions of doxorubicine
ES8303317A1 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof.
JPS53103936A (en) Electroplating solution
JPS52122621A (en) Improvement of herbicidal effect of sodium chlorate
IE791894L (en) Imidazole derivatives
Sangalang et al. Studies on the mitigation of acid precipitation-induced effects on adult Atlantic salmon(Salmo salar), 1987 experiment.
Oksiyuk et al. Use of higher aquatic vegetation for improving water quality and stabilizing canal banks
VOROTNYK ROLE OF MG IN THE FORMATION OF SOLONETZIC SOILS ON IRRIGATION WITH MINERALIZED WATERS
IE33683L (en) Disinfectant compositions
CA2308660A1 (en) Stable aqueous pharmaceutical composition comprising tezosentan